Botanical species · safety record

Citrus medica

The EFSA Compendium of Botanicals holds 5 constituent measurements and 2 adverse-effect records for Citrus medica. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Citrus medica L.

5Constituent measurements
2Safety records
3Cited sources
36Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 36 licensed products naming Citrus medica as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Citrus medica
  • Fruit
  • Fruit(s)
  • Ripe fruit(s)

What the records describe

Constituents measured

  • Myrcene2
  • Alkaloids1
  • Coumarins1
  • Furanocoumarins1

Plant parts

  • Fruit unspecified4
  • Seed3

Preparations

  • Essential oil4
  • Solvent extraction3

Effect types

  • Reproductive2

Target tissues

  • Urogenital2

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
MyrceneFruit unspecifiedEssential oil2.1 PercentGC-MSResolve DOI
AlkaloidsSeedSolvent extractionPhytochemical screeningNo resolvable identifier
CoumarinsFruit unspecifiedEssential oilGC-MSNo resolvable identifier
FuranocoumarinsFruit unspecifiedEssential oilGC-MSNo resolvable identifier
MyrceneFruit unspecifiedEssential oilGC-MSNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
ReproductiveUrogenitalSeedSolvent extractionRat (as animal)Reproduction toxicityNo resolvable identifier
ReproductiveUrogenitalSeedSolvent extractionRat (as animal)Reproduction toxicityNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Di Giacomo, Angelo., Rispoli, Giuseppe. Sweet lemon Citrus limetta . I. Essential oil. Essenze, derivati agrumari, 1969, p. 115-123.
  2. Menichini, Federica., Tundis, Rosa., Loizzo, Monica Rosa., Bonesi, Marco., Provenzano, Eugenio., de Cindio, Bruno., Menichini, Francesco. In vitro photo-induced cytotoxic activity of Citrus bergamia and C. medica L. cv. Diamante peel essential oils and identified active coumarins . Pharmaceutical biology, 2010, vol. 48, no. 9, p. 1059-1065. DOI
  3. Sharangouda., Patil, Saraswati B. Antifertility principles from Citrus medica seeds: anti-implantation, abortifacient and phytochemical studies. Asian journal of experimental sciences, 2010, p. 155-161.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue